2014-09-03 21:40:32 UTC

CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks to an author of the editorial, Dr. Maria T. Abreu of the University of the Miami Miller School of Medicine, Miami, Florida; Plus, summaries of top stories from this month's issue of GI and Hepatology News.



Yarur AJ, Abreu MT. Back to the Beginning: Restarting Infliximab in Inflammatory Bowel Disease Patients With Prior Loss of Response. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1482-1484
Full Text



Related article:
Baert F, Drobne D, Gils A, et al. Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1474-1481



Duration: 17.32m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ



More on IBD

2017 AGA Postgraduate Course

May 6, 2017

Registration is now open for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Register by March 22 and save.

Digestive Disease Week® (DDW)

May 6, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Inflammatory Bowel Diseases and Other Inflammatory Pathologies of the GI Tract

March 21, 2017

Receive up-to-date information on the pathogenesis of the disease process and bridge the gap between state-of-the-art practice and current practices in order to provide a high quality, comprehensive, multidisciplinary approach to patients with IBD.